PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

MD Anderson acquires inducible switch technologies for cell therapy

Asset purchase allows MD Anderson to incorporate CaspaCIDe® and GoCAR ® technologies into its cell therapy programs, out-license technology to interested parties

2024-02-22
(Press-News.org) HOUSTON ― The University of Texas MD Anderson Cancer Center today announced it has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDe® switch platform and the GoCAR® platform. The transaction also includes clinical-grade stocks of rimiducid, an agent used to trigger the switches.

As a result of this acquisition, MD Anderson may incorporate these platforms into its own cell therapy programs. The institution also intends to make the technology widely available via non-exclusive licenses to other academic institutions and to biopharmaceutical companies.

MD Anderson plans to focus on using the CaspaCIDe technology as a safety feature of cell therapies in development. The safety switch incorporates an inducible enzyme known as caspase-9, which initiates the first step of the apoptosis programmed cell death pathway. The switch can be triggered by rimiducid, leading to rapid elimination of cells containing the CaspaCIDe switch. MD Anderson’s Therapeutics Discovery division also plans to continue the clinical development of rimiducid in order to seek future approval from the Food and Drug Administration.

“We strive each day to advance new, innovative treatment options to improve the lives of our patients, and cell therapies hold tremendous promise as effective immunotherapies,” said Philip Jones, Ph.D., vice president of Research Strategy, Transformation and Operations at MD Anderson. “CaspaCIDe provides a critical safety mechanism which could be triggered as required to reduce side effects, and we look forward to its continued development at MD Anderson.”

Including this safety switch in cell therapies may offer clinicians the ability to quickly limit potential treatment-related toxicities that may occur. Potential applications include cell therapies where cytokine release syndrome and neurotoxicities have been observed, cell therapies targeting novel antigens with on-target/off-tumor safety concerns, and next-generation cell therapy constructs with higher potency.

“When designing novel cell therapies, we must always ensure patient safety remains a top priority. We have explored a variety of associated technologies, and case studies demonstrate that the CaspaCIDe technology is effective in rapidly eliminating the transduced cells,” said Katy Rezvani, M.D., Ph.D., professor of Stem Cell Transplantation and Cellular Therapy. “We have incorporated CaspaCIDe into many of our own cell therapies under investigation, and we are excited about the prospect of broadening the potential applications of this technology in the future.”

Under a previous licensing agreement, MD Anderson has incorporated CaspaCIDe into multiple cellular therapy programs, including certain chimeric antigen receptor (CAR) natural killer (NK) cell therapies and plans for certain CAR T cell therapies. The current acquisition includes the previous licenses by MD Anderson and eliminates certain downstream financial obligations required under those licenses.

The asset acquisition also includes the transfer of certain intellectual property related to Bellicum’s GoCAR-T™ and GoCAR-NK™ technologies. Using the rimiducid-based switch system, GoCAR cell therapies feature an inducible MyD88/CD40 (iMC) activation switch designed to enhance proliferation and functional persistence of adoptive cell therapies by resisting exhaustion and by driving production of immunomodulatory cytokines to overcome inhibitory signals from the tumor microenvironment. GoCAR cell therapies may be particularly well-suited for use in solid tumors given their immune suppressive tumor microenvironment.

Read this press release in the MD Anderson Newsroom.

 

- 30 -

END



ELSE PRESS RELEASES FROM THIS DATE:

UTSA doctoral student studies solutions to prevent contaminated water sources

UTSA doctoral student studies solutions to prevent contaminated water sources
2024-02-22
From Bangladesh to India to Texas, Tom Varner is leveraging his research to improve sources for drinking water around the world. Varner, a UTSA doctoral student in environmental science and engineering, explored the mobility of arsenic from the sediments surrounding the Meghna River in Bangladesh as part of a National Science Foundation-funded project. The river flows through central Bangladesh, where elevated concentrations of arsenic in the groundwater threaten the welfare of millions of people. Long-term exposure to arsenic, which is toxic when ingested, can lead ...

Treating newly-diagnosed Crohn’s patients with advanced therapy leads to dramatic improvements in outcomes

2024-02-22
A large-scale clinical trial of treatment strategies for Crohn’s disease has shown that offering early advanced therapy to all patients straight after diagnosis can drastically improve outcomes, including by reducing the number of people requiring urgent abdominal surgery for treatment of their disease by ten-fold. The PROFILE trial, led by researchers at the University of Cambridge, involved 386 patients with newly-diagnosed active Crohn’s disease. Recruiting from 40 hospitals across the UK, and supported by the National Institute for Health and Care Research (NIHR) Clinical Research Network, it sought to test whether a biomarker – a genetic signature ...

Uncovering anxiety: Scientists identify causative pathway and potential cures

Uncovering anxiety: Scientists identify causative pathway and potential cures
2024-02-22
Anxiety-related disorders can have a profound impact on the mental health and quality of life of affected individuals. Understanding the neural circuits and molecular mechanisms that trigger anxiety can aid in the development of effective targeted pharmacological treatments. Delta opioid receptors (DOP), which localize in the regions of the brain associated with emotional regulation, play a key role in the development of anxiety. Several studies have demonstrated the therapeutic effects of DOP agonists (synthetic compounds which selectively bind to DOPs and mimic the effect of ...

Stronger storms free more nutrients from mud flats

Stronger storms free more nutrients from mud flats
2024-02-22
If storms become stronger in the future due to climate change, more nitrogen may be released from the bottom of coastal seas. This is shown by research of marine biogeochemist Dunia Rios-Yunes at NIOZ in Yerseke. Rios-Yunes will defend her PhD-thesis today at the University of Utrecht. “The dynamics of nutrients in deltas and estuaries have been a bit of a blind spot for marine science, so far”, she says.  Inflatable couch  For her experiments, Rios-Yunes spent many hours on an inflatable couch on ...

New study is first step in predicting carbon emissions in agriculture

2024-02-22
MINNEAPOLIS / ST. PAUL (02/19/2024)—For the first time, researchers at the University of Minnesota Twin Cities (UMN) and the University of Illinois Urbana-Champaign (UIUC) have demonstrated that it is possible to provide accurate, high-resolution predictions of carbon cycles in agroecosystems, which could help mitigate the impacts of climate change. The study by scholars from the UMN-led National Artificial Intelligence Institute for Climate-Land Interactions, Mitigation, Adaptation, Tradeoffs and Economy (AI-CLIMATE) and UIUC-led Agroecosystem Sustainability ...

Air pollution hides increases in rainfall

Air pollution hides increases in rainfall
2024-02-22
We know that greenhouse gas emissions like carbon dioxide should increase rainfall. The emissions heat the atmosphere, causing a one-two punch: warmer oceans make it easier for water to evaporate, and warmer air can hold more water vapor, meaning more moisture is available to fall as rain. But for much of the 20th century, that increase in precipitation didn’t clearly show up in the data. A new study led by researchers at the Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley ...

Damage to cell membranes causes cell aging

Damage to cell membranes causes cell aging
2024-02-22
Our cells are surrounded by a fragile membrane that’s only 5 nanometers thick, 1/20 of a soap bubble. Cells are easily damaged by physiological activities, including muscle contraction and tissue injury. To cope with such damage, cells are equipped with mechanisms that can repair membrane damage to a certain degree. Mechanical damage to the cell membrane was previously believed to trigger two simple cellular outcomes: recovery or death. In this study, however, the researchers uncovered a third outcome – cellular senescence.  “When I started this project, I simply aimed to understand ...

Mice surprise: Australian researchers discover new native species

Mice surprise: Australian researchers discover new native species
2024-02-22
Australia can lay claim to two new species of native rodent thanks to a study from The Australian National University (ANU).  The aptly named delicate mouse was previously thought to be a single species spanning a massive stretch of the country from the Pilbara in Western Australia, across parts of the Northern Territory and through Queensland down to the New South Wales border.   But researchers at ANU and CSIRO thought there might be more to the story.   Lead author Dr Emily Roycroft, from ANU, said we now know there ...

Latest research redefines neurodevelopmental risks, outcomes for congenital heart disease

2024-02-22
Statement Highlights: A new American Heart Association scientific statement updates more than a decade of research identifying, managing and preventing neurodevelopmental delays and disorders among people with congenital heart disease. The new statement outlines important changes since the Association’s last statement in 2012, such as revised criteria to determine which children and adults are at high risk for neurological developmental delays and disorders, as well as an updated list of factors that may increase the risk. Critical next ...

Researchers discover underlying cause of “brain fog” linked with Long COVID

Researchers discover underlying cause of “brain fog” linked with Long COVID
2024-02-22
Today, a team of scientists from Trinity College Dublin and investigators from FutureNeuro announced a major discovery that has profound importance for our understanding of brain fog and cognitive decline seen in some patients with Long COVID. In the months after the emergence of the novel coronavirus SARS-CoV2 in late 2019 a patient-reported syndrome termed Long-COVID began to come to the fore as an enduring manifestation of acute infection.    Long COVID has up to 200 reported symptoms to date, but in general patients report lingering symptoms such as fatigue, ...

LAST 30 PRESS RELEASES:

Community partners key to success of vaccine clinic focused on neurodevelopmental conditions

Low-carbon collaborative dual-layer optimization for energy station considering joint electricity and heat demand response

McMaster University researchers uncover potential treatment for rare genetic disorders

The return of protectionism: The impact of the Sino-US trade war

UTokyo and NARO develop new vertical seed distribution trait for soybean breeding

Research into UK’s use of plastic packaging finds households ‘wishcycle’ rather than recycle – risking vast contamination

Vaccine shows promise against aggressive breast cancer

Adverse events affect over 1 in 3 surgery patients, US study finds

Outsourcing adult social care has contributed to England’s care crisis, argue experts

The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests

New therapeutic approach for severe COVID-19: faster recovery and reduction in mortality

Plugged wells and reduced injection lower induced earthquake rates in Oklahoma

Yin selected as a 2024 American Society of Agronomy Fellow

Long Covid could cost the economy billions every year

Bluetooth technology unlocks urban animal secrets

This nifty AI tool helps neurosurgeons find sneaky cancer cells

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NYC's ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Meteorite contains evidence of liquid water on Mars 742 million years ago

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

Which risk factors are linked to having a severe stroke?

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

[Press-News.org] MD Anderson acquires inducible switch technologies for cell therapy
Asset purchase allows MD Anderson to incorporate CaspaCIDe® and GoCAR ® technologies into its cell therapy programs, out-license technology to interested parties